MICHELLE PATURZO: Open Payments
NPI 1003464603 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,350 in 99 payments from 17 companies in 2025. Trend: 2023 $826 · 2024 $1,545 · 2025 $2,350
Food & beverage: $2,270Education: $80
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $583 |
| Regeneron Healthcare Solutions, Inc. | 21 | $475 |
| Novartis Pharmaceuticals Corporation | 14 | $288 |
| GENZYME CORPORATION | 4 | $194 |
| Organon LLC | 10 | $110 |
| GlaxoSmithKline, LLC. | 4 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| Grifols USA, LLC | 3 | $84 |
| Genentech USA, Inc. | 4 | $83 |
| Globus Medical, Inc. | 2 | $64 |
Products named: DUPIXENT, TEZSPIRE, BREZTRI, XOLAIR, Rhapsido, Senza, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across CO — which companies pay providers there.
